Growth Metrics

Dexcom (DXCM) Receivables - Net (2016 - 2026)

Dexcom has reported Receivables - Net over the past 17 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly Receivables - Net fell 5.77% to $1.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Mar 2026, down 5.77% year-over-year, with the annual reading at $1.2 billion for FY2025, 20.92% up from the prior year.
  • Receivables - Net was $1.1 billion for Q1 2026 at Dexcom, down from $1.2 billion in the prior quarter.
  • Over five years, Receivables - Net peaked at $1.3 billion in Q2 2025 and troughed at $544.5 million in Q1 2022.
  • The 5-year median for Receivables - Net is $973.9 million (2023), against an average of $904.7 million.
  • Year-over-year, Receivables - Net surged 53.67% in 2024 and then dropped 5.77% in 2026.
  • A 5-year view of Receivables - Net shows it stood at $713.3 million in 2022, then surged by 36.53% to $973.9 million in 2023, then rose by 3.27% to $1.0 billion in 2024, then rose by 20.92% to $1.2 billion in 2025, then dropped by 10.48% to $1.1 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Receivables - Net are $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025).